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Colonization of the gastrointestinal tract of cattle by Shiga toxin-producing Escherichia coli increases the risk of contamination of
food products at slaughter. Our study aimed to shed more light on the mechanisms used by E. coli O157:H7 to thrive and compete
with other bacteria in the gastrointestinal tract of cattle. We evaluated, in vitro, bovine intestinal mucus and its constituents in
terms of their capacity to support growth of E. coli O157:H7 in presence or absence of fecal inoculum, with and without various
enzymes. Growth of E. coli O157:H7 and total anaerobic bacteria were proportionate to the amount of mucus added as substrate.
Growth of E. coli O157:H7 was similar for small and large intestinal mucus as substrate, and was partially inhibited with addition
of fecal inoculum to cultures, presumably due to competition from other organisms. Whole mucus stimulated growth to the
greatest degree compared with other compounds evaluated, but the pathogen was capable of utilizing all substrates to some
extent. Addition of enzymes to cultures failed to impact growth of E. coli O157:H7 except for neuraminidase, which resulted in
greater growth of E. coli O157 when combined with sialic acid as substrate. In conclusion, E. coli O157 has capacity to utilize small
or large intestinal mucus, and growth is greatest with whole mucus compared with individual mucus components. There are two
possible explanations for these ﬁndings (i) multiple substrates are needed to optimize growth, or alternatively, (ii) a component of
mucus not evaluated in this experiment is a key ingredient for optimal growth of E. coli O157:H7.
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Implications
Escherichia coli O157:H7 is causing, every year, deaths and
costly recalls worldwide, yet little is known of the relationship
between E. coli O157:H7 and the gastrointestinal colonization
of cattle. These studies offer insight regarding the potential of
E. coli O157:H7 to utilize intestinal mucus and its components
as substrates for growth in the gastrointestinal tracts of cattle.
Factors inﬂuencing intestinal mucus secretion in cattle may be
important determinants of E. coli O157:H7 colonization rates
and, thus, important components in the development of inno-
vative and efﬁcient preharvest interventions to prevent food
chain contaminations.
Introduction
Escherichia coli are commensal copiotroph bacteria found
in the intestinal mucus layer (Montagne et al., 2000;
Moller et al., 2003; Naylor et al., 2003) of mammalian
digestive tracts (Ihssen and Egli, 2005). Some strains of
E. coli are pathogenic to humans, such as the well known
Enterohemorrhagic (EHEC) E. coli O157:H7. Infection with
EHEC often originates from the ingestion of contaminated
food products. E. coli O157:H7 is non-pathogenic to cattle,
and cattle are thus recognized as an important reservoir for
the pathogen. Exposure in human populations can occur
either directly through contact with cattle or their waste
products, or indirectly through water, meat or other food
products that have been contaminated by cattle feces. To
control contamination in the food chain, it is essential to
understand how this pathogen is able to grow and compete
with other bacteria in the bovine gastrointestinal tract.
Previous studies have shown that bovine intestinal mucus
supports bacterial colonization and can selectively inﬂuence
composition of the bacterial population (Deplancke and
Gaskins, 2001), yet little is known of the nutrients and
metabolic pathways used by E. coli O157:H7 (Miranda et al.,
2004). Intestinal mucus is comprised of mucins, glycoproteins,
glycolipids, epithelial cell debris and electrolytes (Conway et al.,
2006). Degradation of the complex mucin components to
simpler, more readily fermentable substrates requires multiple
enzymes. Proteases convert the mucus from viscous to ﬂuid
state and endoglycosidases act at internal sites to release† E-mail: jdrouill@ksu.edu
Animal (2014), 8:5, pp 731–737 © The Animal Consortium 2014
doi:10.1017/S1751731114000147
animal
731
oligosaccharide fragments. Sialic acid is then removed
from these fragments by neuraminidases, allowing the degra-
dation of the remaining chain by exo-glycosidases and
β-galactosidases (Corﬁeld et al., 1992). E. coli does not produce
polysaccharide-degrading enzyme (Chang et al., 2004), thus
restricting its capacity for carbohydrate utilization to mono- or
disaccharides (Mayer and Boos, 2005). Moreover, E. coli O157:
H7 lacks neuraminidase activity (Hoskins et al., 1985), and
therefore has limited ability to degrade complex mucin mole-
cules. The organism is thus dependent upon other anaerobes
present within the gastrointestinal tract to degrade mucin
polysaccharides and release fragments beneﬁcial for their
growth (Jones et al., 2008). Analysis of bovine small intestinal
contents revealed the presence of free mucus-derived carbo-
hydrates, including galactose (1.43 mM), GlcNAc (0.89 mM),
GalNAc (0.72 mM), fucose (0.64 mM), mannose (0.50 mM)
and N-acetyl neuraminic acid (0.09 mM; Bertin et al., 2013), all
of which can be metabolized by E. coli O157:H7. Nevertheless,
to be maintained in the gastrointestinal tract of cattle, E. coli
O157:H7 needs to compete with other bacteria to colonize the
mucus layer. In the 1980s, it was believed that bacteria have a
single preferred nutrient as a substrate for growth (Freter,
1988); however, recent studies have illustrated that E. coli
relies on a diverse range of nutrients for its growth (Chang
et al., 2004), allowing EHEC to proliferate in cattle and shed in
their feces, thus providing opportunity for contamination of
carcasses at harvest. Fox et al. (2009) demonstrated that
galactose, gluconic acid, glucuronic acid, galacturonic acid,
glucosamine and porcine mucin increased growth of NalR
E. coli in fecal fermentations. In addition, Bertin et al. (2013)
showed that EDL933, an EHEC strain, consumed the free
mucus-derived carbohydrates present in bovine small intestinal
content more rapidly than resident microﬂora. The following
in vitro experiments were conducted to gain further insight on
the mechanisms used by E. coli O157:H7 to thrive and compete
with other bacteria of the bovine gastrointestinal tract.
Fermentation assays were performed on small or large bovine
intestinal mucus, or their constituents, with or without various
enzymes, and in the presence or absence of fecal inoculum.
Material and methods
Intestinal mucus harvest
Intestinal tissues were collected from freshly harvested cattle
and, immediately, transported to the Preharvest Food Safety
Laboratory (Kansas State University, Manhattan, KS, USA).
Sections of the ileum and colon were excised with sterile
scissors and washed with a HEPES (N-2-hydroxyethylpiperazine-
N'-2-ethanesulfonic acid)-Hanks buffer (8.0 g of NaCl, 0.4 g of
KCl, 0.185 g of CaCl2∙2H2O, 0.2 g of MgSO4∙7H2O, 0.05 g of
Na2HPO4, 0.35 g of KH2PO4, 2.6 g of HEPES; adjusted to pH 7.4)
to remove digesta. Mucus was collected from each of the sec-
tions by gently scraping the epitheliumwith a sterile microscope
slide. Harvested mucus was centrifuged twice at 27 000×g for
20 min to remove cellular debris and impurities. Supernatant
containing the crude mucus was dialyzed overnight at 4°C in
HEPES-Hanks buffer, lyophilized and stored at −20°C.
Bacterial strains
Five Shiga toxin-producing E. coli O157:H7 strains (STEC;
01-2-1863, 01-2-7443, 01-2-10004, 01-2-10530 and 01-2-
12329), isolated from feedlot pen fecal samples by Sargeant
et al. (2003), were used in this experiment. Mutants resistant
to nalidixic acid (NalR) were obtained by serial transfer
into Luria-Bertani broth (Neogen Inc. Baltimore, MD, USA)
containing increasing concentrations of nalidixic acid (from
0.2 to 50 mg/l; Sigma-Aldrich, St. Louis, MO, USA) following
the procedure outlined by Schamberger et al. (2004).
Bacterial inoculum preparation
All ﬁve NalR STEC were plated onto tryptic soy agar
containing 5% sheep’s blood (Blood agar; Thermo Fisher
Scientiﬁc, Waltham, MA, USA) and were incubated overnight
at 37°C. A single colony was picked from each plate and
grown overnight at 37°C in 10 ml tryptic soy broth (TSB;
Thermo Fisher Scientiﬁc) to be transferred to ﬁve other 9-ml
TSB tubes. After incubation at 37°C for 18 h, the ﬁve broths
were combined in equal proportions to create a ﬁve-strain
cocktail of NalR STEC.
Fecal inoculum preparation
Feces were collected by rectal palpation from a steer fed a
concentrate-based diet and transported to the Preharvest
Food Safety Laboratory in a pre-warmed thermos. Feces were
blended in an Osterizer blender for 60 s with McDougall’s
buffer (pH 6.8; McDougall, 1948) in a 1 to 6 ratio (weight/
volume) under a stream of CO2, strained through two layers of
cheese cloth, and the resulting fecal suspension was collected.
In vitro fermentation assay
Fecal inoculum or McDougall’s buffer were added to tubes
containing substrates to be tested in a 1 : 2 ratio (volume/
volume) under a stream of CO2 to maintain anaerobic
environment. Tubes were inoculated with the ﬁve-strain
bacterial inoculum to achieve a ﬁnal concentration of 103
CFU/ml, gassed with CO2, capped with butyl stoppers ﬁtted
with Bunsen valves, and incubated on a shaker at 40°C.
A volume of 100 µl was extracted from each fermentation
tube after 0, 6, 8, 12 and/or 24 h and diluted into 900 µl of
Butterﬁeld’s phosphate buffer (26.22 g of KH2PO4/l; pH 7.2).
Subsequent dilutions (100 µl) were plated in triplicate onto
sorbitol MacConkey agar (Becton Dickinson, Franklin Lakes,
NJ, USA), supplemented with ceﬁxime (0.05 mg/l), potassium
tellurite (2.5 mg/l), and nalidixic acid (50 mg/l; CTN-SMAC).
Plates were incubated at 37°C for 24 h and non-sorbitol
fermenting colonies were enumerated to determine NalR
STEC concentrations.
Nitrogen and organic matter (OM) content of mucus
OM contents of mucus harvested from the small and
large intestine were determined by ashing the samples
(Undersander et al., 1993). Brieﬂy, mucus samples were
dried in aluminum pan overnight at 105°C to determine dry
matter content. Pans were then heated to 450°C overnight,
slowly cooled and transferred to a desiccator to be weighted.
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OM percentage was obtained by subtracting ash content
from a hundred. A bicinchoninic acid assay (Thermo Fisher
Scientiﬁc) was performed to assess CP content of samples.
In vitro fermentations performed in this study were carried
out in tubes containing mucin from the small and large
intestine at equal levels of OM (4.4 mg of OM/ml; 7.5 and
9.2 µg of protein/ml for small and large intestinal mucus,
respectively) unless stated otherwise.
Increasing concentrations of mucus
Increasing concentration of mucus from the small intestine
(0, 0.5, 1.0, 2.0, 4.4, 10 and 15 mg OM per ml of inoculum)
were tested in an in vitro fermentation assay as described
previously. In addition, aliquots obtained at different sampling
times were plated in triplicate onto tryptic soy agar (TSA;
Thermo Fisher Scientiﬁc) to allow enumeration of total anae-
robic bacteria. The TSA plates were inoculated with 100 µl of
the cultures and incubated at 40°C in a Coy rigid anaerobic
chamber (Coy Laboratory Products, Grass Lake, MI, USA)
containing 90% nitrogen, 5% CO2 and 5% hydrogen.
Mucus and mucus components
Mucin from the ileum and the colon (4.4 mg of OM/ml), as
well as mucus components such as the lipid L-α-phosphati-
dylserine, (1 mg/ml; CAS number: 840032P, Avanti Polar
Lipids Inc., Alabaster, AL, USA), and the carbohydrates:
D-gluconic acid (CAS number: G9005), D-glucuronic acid (CAS
number: 6556-12-3), N-acetyl-D-glucosamine (CAS number:
7512-17-6), D-galacturonic acid (CAS number: 91510-62-2),
sialic acid (CAS number: 131-48-6), galactose (CAS number:
G5388) and mannose (10 mg/ml; CAS number: 3458-28-4,
Sigma-Aldrich) were tested as growth substrate in the in vitro
fermentation assays.
Enzymes and enzyme inhibitors
All enzymes and inhibitors were added to tubes containing
small or large intestinal mucin and McDougall’s buffer to be
subjected to a fermentation assay. A protease from bovine
pancreas (CAS number: 9001-92-7), an endoglycosidase
from Elizabethkingia meningoseptica (PNGase F; CAS number:
83534-39-8), a neuraminidase from Clostridium perfringens
(CAS number: 9001-67-6) and a lipase from Candida antartica
(CAS number: 9001-62-1) all were purchased from Sigma-
Aldrich and tested at a concentration of one unit per milliliter of
McDougall’s buffer. β-Galactosidase (CAS number: 9031-11-2;
Sigma-Aldrich) and phenylethyl β-D-thiogalactopyranoside
(PETG; CAS number: P-1692; Invitrogen, Grand Island, NY, USA)
were inoculated at a concentration of 100 and 200 µM,
respectively. Finally, bacterial protease inhibitor cocktail
containing 4-(2-aminoethyl)benzenesulfonyl ﬂuoride, EDTA
disodium salt, bestatin, pepstatin A, and E-64 (P8465;
Sigma-Aldrich) was added at two different concentrations,
0.25 and 2.5 ml/g E. coli O157 culture.
Statistical analysis
Colony forming units (CFU) counts were transformed to the
log10 scale. Statistical analysis of fermentation assays were
performed using the MIXED procedure of SAS (SAS 9.2, Cary,
NC, USA). Sampling times, substrate types, presence or
absence of fecal inoculum and their interactions were included
in the model as ﬁxed effects. Effect of increasing level of small
intestinal mucus on E. coli O157:H7 and total anaerobes were
analyzed using the MIXED procedure of SAS and linear con-
trasts. Sampling time, small intestinal mucus concentration,
and the interaction of sampling time× small intestinal mucus
concentration were included as ﬁxed effects in the model.
Differences were considered different at P< 0.01 and P< 0.05.
Results
Mucus anatomical origin and composition
The analysis of the nitrogen and OM content of the mucus
collected at the ileum and colon revealed slight differences in
composition with 1.068 µg of protein and 627 µg of OM per
milligram of small intestinal mucus v. 0.910 µg of protein
and 442.6 µg of OM per milligram of large intestinal mucus.
Figure 1 depicts the growth of NalR E. coli O157:H7 in pre-
sence or absence of a fecal inoculum, with small intestinal
mucus, large intestinal mucus, or no substrate overtime. It
reveals no signiﬁcant differences (P> 0.10) in growth when
mucus from the ileum and colon were used as substrate. The
bacteria increased from 103 CFU/ml of culture, at hour 0, to
between 107 and 108 CFU/ml at hour 8. An overall time effect
was observed on the growth of the bacteria (P< 0.01);
however, there was no signiﬁcant difference between hour 8
and hour 12. The presence or absence of fecal inocula in the
culture did affect growth of E. coli O157:H7 (P< 0.01). Final
concentration of the pathogen was 107 CFU/ml in tubes
without fecal inoculum, compared with 105 CFU/ml in tubes
containing fecal inoculum.
Increasing concentrations of mucus
Growth of total anaerobic bacteria and NalR E. coli O157:H7
was tested with increasing levels of small intestinal mucus.
Growth of total anaerobes was signiﬁcantly inﬂuenced by
the levels of substrate addition at hours 6 and 12 (Table 1; SI
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Figure 1 Growth of NalR E. coli O157:H7, with buffer (○), small (▵) or
large (□) intestinal mucus as a substrate, in presence (bold symbols) or
absence of fecal inoculum (open symbols). s.e.m. = 0.21, effect of time,
P< 0.01; effect of mucus origin, P> 0.01; effect of addition of fecal
inoculum, P< 0.01.
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concentration effect, P< 0.01). A linear increase in anaerobe
concentration was observed with increasing concentration of
small intestinal mucus (linear effect, P< 0.01). Cultures
containing 15 mg of mucus OM/ml supported a 28% increase
in anaerobe growth after 12 h incubation compared with
cultures without mucus. Growth of NalR E. coli O157:H7
increased at every time point in response to increased con-
centrations of mucus (linear effect, P< 0.01). Counts of NalR
STEC counts were increased by 72% in the presence of 15 mg
of mucus OM/ml of culture compared with tubes containing
0 mg of mucus/ml after 12 h of fermentation.
Mucus and mucus components
Figure 2 depicts the growth of E. coli O157:H7 after 8 h of
anaerobic incubation with or without fecal inoculum and
either whole mucus or selected components of mucus as
substrates. In presence of a fecal inoculum, all substrates
increased the growth of E. coli O157:H7 (P< 0.05), with the
notable exceptions of mannose and galactose. Growth was
numerically greatest with L-α-phostatidylserine and glucuronic
acid as substrates, but was not different from that obtained
with whole mucus from the small or large intestines (P> 0.179).
In the absence of fecal inoculum, all of the mucus components
tested, with the exception of L-α-phosphatidylserine, increased
growth of the bacteria in comparison to the batch containing no
substrate (P< 0.05). Mucus originating from the large and small
intestines supported greater growth than individual mucus
fractions (P< 0.05), which is in contrast to results observed in
the presence of fecal inoculum. Gluconic acid was the only
single compound to yield growth similar to that obtained with
whole large intestinal mucus (P> 0.09), but still was less than
that observed for whole small intestinal mucus (P< 0.0001).
Figure 3 illustrates growth of E. coli O157:H7 in response
to small intestinal mucus or sialic acid substrates, in presence
or absence of a fecal inoculum. NalR STEC growth was sig-
niﬁcantly lower in sialic acid than in mucus (P< 0.01) in
absence of fecal inoculum. When fecal inoculum was added
to cultures with small intestinal mucus, there was a decrease
in growth of NalR E. coli compared with similar cultures
without fecal inoculum (P< 0.0001). When fecal inoculum
was added to cultures containing sialic acid, growth of E. coli
O157:H7 increased in comparison to similar cultures without
fecal inoculum (P< 0.0002). The addition of neuraminidase
to cultures containing sialic acid fermentation increased
growth of the bacteria compared with tubes containing sialic
acid with (P< 0.025) or without fecal inoculum (P< 0.0001),
Table 1 Growth of NalR Escherichia coli O157:H7 and total anaerobes with increasing levels of small intestinal (SI) mucus over a 12 h fermentation
at 40°C
SI mucus concentration (mg of OM/ml) P-value
Hour 0 0.5 1 2 4.4 10 15 TRT linear
E. coli O157:H7(CFU/ml, Log 10) 0 3.15 3.13 3.08 3.18 3.16 3.38 3.40 >0.05 >0.05
6 4.08 4.29 4.86 4.66 5.01 4.90 5.74 <0.01 <0.01
8 4.18 4.50 4.62 5.05 4.97 5.12 5.88 <0.01 <0.01
12 4.64 4.73 4.64 4.90 5.06 5.15 5.84 <0.05 <0.01
Total anaerobe (CFU/ml, Log 10) 0 6.82 6.82 6.82 6.82 6.82 6.82 6.82 >0.05 >0.05
6 7.88 7.89 7.96 7.91 8.95 9.03 8.98 <0.01 <0.01
8 8.57 8.57 8.13 8.45 8.56 8.73 8.86 >0.05 >0.05
12 7.71 8.04 8.00 8.10 8.11 8.62 8.72 <0.01 <0.01
s.e.m. = 0.3.
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Figure 2 Growth of NalR E. coli O157:H7 after 8 h incubation at 40°C with mucus or single mucus components as a substrate for growth, in presence or
absence of fecal inoculum. Means are compared within fecal inoculum groups. Means without a common superscript letter are different, P< 0.05.
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but growth still was less than that of cultures containing
small intestinal mucus as substrate (P< 0.0001).
Enzymes and enzyme inhibitors
Figure 4 illustrates our attempt to evaluate the stimulatory
effect of mucus degrading enzymes on growth of E. coli
O157:H7. There were no effects of protease, endoglycosidase,
lipase, β-galactosidase, neuraminidase or protease inhibitor
addition to cultures (data not shown; P> 0.05). Conversely,
addition of β-galactosidase enzyme inhibitor increased growth
of NalR E. coli O157:H7 cultured with either small or large
intestinal mucus (P<0.05).
Discussion
Previous studies have shown heterogeneity in mucus com-
position and thickness across the human and rat gastro-
intestinal tracts (Atuma et al., 2001; Freitas et al., 2002;
Robbe et al., 2004). Bovine mucus is believed to display a
certain level of heterogeneity between the different sections
of the intestine, and this diversity is considered partly
responsible for the bacterial tropism (Robbe et al., 2004;
Snider et al., 2009). Our analysis of the ileum and colon
mucus composition revealed no major differences in nitrogen
or OM content. Moreover, pathogenic E. coli was equally
capable of growing on large and small intestinal mucus.
These observations led us to postulate that heterogeneity in
bovine mucus is either less important than in other species or
that differences in composition do not appreciably inﬂuence
bacterial growth.
Growth of the pathogen was attenuated by the presence
or absence of fecal inoculum in the assay. In presence of fecal
inoculum, NalR E. coli growth was reduced by at least 2 log
units, which likely is due to competition for nutrients
between fecal bacteria and our introduced strains of NalR
E. coli O157:H7. These observations are consistent with the
principle of competitive exclusion (Tkalcic et al., 2003), by
which the presence of other bacteria in the medium limits
substrate availability, thus reducing pathogen growth.
Another interesting observation was the linear increase in
NalR E. coli O157:H7 and total anaerobes with increasing level
of small intestinal mucus. Small intestinal mucus at 15 mg
of OM/ml supported a 2 log increase in growth of both NalR
E. coli O157:H7 and total anaerobes after 12 h incubation. Our
results suggest that intestinal mucus stimulated pathogenic
E. coli and total anaerobe.
NalR E. coli O157:H7 was able to grow on all mucus
components tested in the absence of fecal inoculum,
indicating that the bacteria were able to metabolize all
compounds evaluated. Whole mucus resulted in the greatest
degree of growth, despite the ability of the pathogen to grow
on all substrates. Whole mucus may represent a combination
of substrates that more closely meet requirements of the
pathogen or, alternatively, a component of mucus not tested
in this experiment may be a key ingredient for optimal
growth of NalR E. coli O157:H7. For example, an E. coli
mutant deﬁcient in the catabolic pathway for L-fucose
demonstrated a marked decrease in colonization of the rectal
mucus (Snider et al., 2009). Similar results were observed in
mice and in vitro with E. coli MG1655 (Chang et al., 2004;
Fabich et al., 2008). Fucose is only a minor component of calf
ileal mucus (Montagne et al., 2000), and thus was not
evaluated in this study. In retrospect, it could be a key con-
stituent supporting optimal growth of NalR E. coli O157:H7.
Fox et al. (2009) indicated that, in presence of fecal inocu-
lum, addition of galactose, gluconic acid, glucuronic acid,
glucosamine, galacturonic acid, mannose, galactosamine,
fucose, and porcine mucin, all supported growth of NalR
E. coli O157:H7. However, mannose, fucose and galactosa-
mine addition did not support growth greater than the con-
trol. In the current experiment, in the presence of fecal
inoculum, mannose and galactose were the only two com-
ponents tested that yielded growth not different from the
control. In addition, growth observed with whole bovine
mucus was similar to that observed by Fox et al. (2009) using
porcine mucin, suggesting that compositional differences
may not appreciably inﬂuence bacterial growth.
Cultures of NalR E. coli O157:H7 alone with sialic acid as
substrate resulted in modest bacterial growth, whereas in the
presence of fecal inocula growth of the pathogen closely
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Figure 3 Growth of NalR E. coli O157:H7 in response to small intestinal
mucus (▵) and sialic acid (○), in presence (bold symbols) or absence of
fecal inoculum (open symbols) and in response to sialic acid with
neuraminidase (◊). Effect of time, P< 0.01; effect of substrate, P< 0.01;
effect of addition of fecal inoculum, P< 0.01; interaction between
substrate and fecal inoculum, P< 0.01.
a
b
c, d c d
0
1
2
3
4
5
6
7
8
9
N
o 
su
bs
tra
te
LI
 m
uc
us
LI
 m
uc
us
 w
/
be
ta
-
ga
la
ct
os
id
as
e
in
hi
bi
to
r 
SI
 m
uc
us
SI
 m
uc
us
 w
/
be
ta
-
ga
la
ct
os
id
as
e
in
hi
bi
to
r 
N
al
R
 
E.
 c
ol
i O
15
7:
H7
CF
U/
m
L,
 L
og
10
Figure 4 Growth of NalR E. coli O157:H7 after 8 h incubation at 40°C
with no substrate, small (SI) or large (LI) intestinal mucus and in presence
or absence of β-galactosidase inhibitor. Means without a common
superscript letter are different, P< 0.05.
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resembled that obtained with whole mucus. The E. coli
strains used in our experiment appeared to have limited
ability to use sialic acid, but seem capable of using inter-
mediate products or metabolites synthesized by other fecal
bacteria in the degradation of sialic acid. This observation
could explain partly why feeding distiller’s grains to feedlot
cattle stimulates E. coli O157:H7 shedding (Jacob et al.,
2008, 2009). Distiller’s grains are rich in yeasts, which con-
tain up to 3% of their dry mass as sialic acid, (Malhotra and
Singh, 2006). In such conditions, it is conceivable that a
derivative of sialic acid is the active component that stimu-
lates proliferation of the pathogen in cattle fed dried dis-
tiller’s grains. In addition, the EHEC strain O157:H7 used by
Bertin et al. (2013) was able to grow on N-acetyl neuraminic
acid to level comparable to that obtained with N-acetyl
glucosamine, which may indicate a strain speciﬁc ability to
metabolize sialic acid.
One of our initial hypotheses was that E. coli O157:H7
would have little ability to use whole mucus to support its
growth because the organism is not known to produce
endoglycosidase (Chang et al., 2004), but our results suggest
otherwise. First, NalR E. coli O157:H7 grew best on whole
mucus compared with individual compounds. It is possible
that the mucus harvested for this experiment had already
been partially cleaved by the gastrointestinal microﬂora and
was readily available to NalR E. coli O157:H7. This may
explain why addition of protease, endoglycosidase, lipase or
neuraminidase to the medium did not improve growth of the
pathogen. Only β-galactosidase inhibitor had an effect on
the growth of the bacteria and, surprisingly, increased the
NalR E. coli O157:H7. Presence of β-galactosidase activity is
used in chromogenic medium as a means of distinguishing
E. coli O157:H7 from other E. coli which are β-galactosidase
negative and glucuronidase positive. Therefore, we were
expecting the addition of β-galactosidase inhibitor to decrease
growth of the organism. It is possible that galactosides are
more stimulatory to growth of NalR E. coli O157:H7 than
degradation products derived from galactosides, or that the
inhibitor itself was used as a source of nutrient by the bacteria.
The latter explanation seems unlikely, based on the very small
amount of inhibitor (200 µM) added in this assay. Additional
experiments are needed to further investigate this effect.
In conclusion, this series of experiments provided information
regarding metabolism of mucus and mucus components by
pathogenic E. coli O157. Wewere unable, however, to identify a
single component as a key stimulator or inhibitor of growth of
these bacteria. In order to develop innovative and efﬁcient
preharvest intervention measures, it is important to further
investigate the relationship between E. coli O157:H7, or other
STEC, and the gastrointestinal colonization of cattle.
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